Superior inhibition of disease-relevant inflammatory mediators and cell biology by combined leflunomide and hydroxychloroquine supports rationale for combination therapy in pSS patients
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY(2018)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined